4
Changes in Ownership
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed Acc 0001127602-23-022480
EVP, Corp Strategy & Develop sold 700 shares at $216.52 ($151,564)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| LaPlume Joseph W EVP, Corp Strategy & Develop | 2023-08-10 | Sale | −700 | $216.52 | $151,564 | 24,983 | D: show line 1 in the form |
| Open-market sales · 700 sh · avg $216.52 · $151,564 | |||||||
Loading xslF345X05/form4.xml…